These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25545858)

  • 41. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
    Rigotti NA; Pipe AL; Benowitz NL; Arteaga C; Garza D; Tonstad S
    Circulation; 2010 Jan; 121(2):221-9. PubMed ID: 20048210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study.
    McNaughton B; Frohlich J; Graham A; Young QR
    BMC Public Health; 2013 Sep; 13():824. PubMed ID: 24020450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A preliminary investigation of varenicline for heavy drinking smokers.
    Fucito LM; Toll BA; Wu R; Romano DM; Tek E; O'Malley SS
    Psychopharmacology (Berl); 2011 Jun; 215(4):655-63. PubMed ID: 21221531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial.
    Bohadana A; Freier-Dror Y; Peles V; Babai P; Izbicki G
    EClinicalMedicine; 2020 Feb; 19():100228. PubMed ID: 32055787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adherence to varenicline in the COMPASS smoking cessation intervention trial.
    Catz SL; Jack LM; McClure JB; Javitz HS; Deprey M; Zbikowski SM; McAfee T; Richards J; Swan GE
    Nicotine Tob Res; 2011 May; 13(5):361-8. PubMed ID: 21350041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol.
    Berlin I; Dautzenberg B; Lehmann B; Palmyre J; Liégey E; De Rycke Y; Tubach F
    BMJ Open; 2019 May; 9(5):e028832. PubMed ID: 31129603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
    Fagerström K; Gilljam H; Metcalfe M; Tonstad S; Messig M
    BMJ; 2010 Dec; 341():c6549. PubMed ID: 21134997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
    Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
    JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediators of the effect of nicotine pre-treatment on quitting smoking.
    Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
    Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers.
    Kikkawa H; Maruyama N; Fujimoto Y; Hasunuma T
    J Clin Pharmacol; 2011 Apr; 51(4):527-37. PubMed ID: 20551220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
    Kralikova E; Kmetova A; Stepankova L; Zvolska K; Davis R; West R
    Addiction; 2013 Aug; 108(8):1497-502. PubMed ID: 23668486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
    Tashkin DP; Rennard S; Hays JT; Ma W; Lawrence D; Lee TC
    Chest; 2011 Mar; 139(3):591-599. PubMed ID: 20864613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pilot clinical trial of varenicline for smoking cessation in black smokers.
    Nollen NL; Cox LS; Nazir N; Ellerbeck EF; Owen A; Pankey S; Thompson N; Ahluwalia JS
    Nicotine Tob Res; 2011 Sep; 13(9):868-73. PubMed ID: 21498427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.